Search company, investor...

FORMAC Pharmaceuticals N.V.

Founded Year



Unattributed VC | Alive

Total Raised


Last Raised

$2.4M | 15 yrs ago

About FORMAC Pharmaceuticals N.V.

FORMAC is a pharmaceutical R&D company engaged in drug delivery and development. The firm aims to increase pharmaceutical R&D productivity and product value by enhancing the performance of (pre)clinical drug candidates and marketed drugs.

Headquarters Location

Gaston Geenslaan 1



Missing: FORMAC Pharmaceuticals N.V.'s Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: FORMAC Pharmaceuticals N.V.'s Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing FORMAC Pharmaceuticals N.V.

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

FORMAC Pharmaceuticals N.V. is included in 1 Expert Collection, including Biopharma Tech.


Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

FORMAC Pharmaceuticals N.V. Patents

FORMAC Pharmaceuticals N.V. has filed 1 patent.

patents chart

Application Date

Grant Date


Related Topics




Progestogens, Androgens and anabolic steroids, Piperazines, Estranes, Prodrugs


Application Date


Grant Date



Related Topics

Progestogens, Androgens and anabolic steroids, Piperazines, Estranes, Prodrugs



Latest FORMAC Pharmaceuticals N.V. News

Grace licenses Formac's bioavailability enhancement tech

Oct 17, 2017

By Gareth Macdonald WR Grace & Co has licensed rights to a bioavailability enhancement technology from Formac Pharmaceuticals NV. The deal – financial terms of which were not provided – covers patent and know how related to Formac’s mesoporous silica-based technology, which is designed to enhance the oral bioavailability of active pharmaceutical ingredients (APIs). Grace has been manufacturing mesoporous silica for Formac since 2011, when the firms teamed up to commercialize the platform. A year later, Grace released data from a first-in-man study showing the technology can be used to enhance bioavailability. The study showed that a reformulated version of Abbott Laboratories’ cholesterol lowering drug Lipanthyl (fenofibrate) was 54% more bioavailable than the commercial version of the product. Copyright - Unless otherwise stated all contents of this web site are © 2017 - William Reed Business Media Ltd - All Rights Reserved - Full details for the use of materials on this site can be found in the Terms & Conditions

FORMAC Pharmaceuticals N.V. Frequently Asked Questions (FAQ)

  • When was FORMAC Pharmaceuticals N.V. founded?

    FORMAC Pharmaceuticals N.V. was founded in 2007.

  • What is FORMAC Pharmaceuticals N.V.'s latest funding round?

    FORMAC Pharmaceuticals N.V.'s latest funding round is Unattributed VC.

  • How much did FORMAC Pharmaceuticals N.V. raise?

    FORMAC Pharmaceuticals N.V. raised a total of $2.4M.

  • Who are the investors of FORMAC Pharmaceuticals N.V.?

    Investors of FORMAC Pharmaceuticals N.V. include Hunza Ventures, Vlaams Innovatiefonds, Gemma Frisius Fonds and Allegro Investment Fund.

  • Who are FORMAC Pharmaceuticals N.V.'s competitors?

    Competitors of FORMAC Pharmaceuticals N.V. include Aura Biosciences, Hutchison MediPharma, Anterios, Catalent, Quinnova Pharmaceuticals, Glide Pharma, Pacira Biosciences, Azaya Therapeutics, MedManage Systems, Travanti Pharma and 12 more.

Compare FORMAC Pharmaceuticals N.V. to Competitors

Kucera Pharmaceutical Company

Kucera Pharmaceutical Company is based in Winston-Salem, NC. The company started with a drug delivery approach that combined or conjugated delivery molecules with therapeutic molecules as a platform technology, both to improve the properties of the attached therapeutic molecules (making them orally available and improving distribution) and to extend patent life.

Core Tech Solutions

Core Tech Solutions, Inc. is engaged in the development of Transdermal, Dermal and Tran mucosal Delivery Systems for the treatment of a variety of indications. The primary mission of the company is to provide transdermal drug delivery development to the worlds pharmaceutical companies. In addition to offering research and development on a contractual basis, Core Tech Solutions possesses the facilities and expertise to perform or coordinate all other aspects of commercialization including Feasibility Studies, Prototype Development, Formulation Optimization, Clinical Trials, Regulatory Compliance, Process Scale-up, and Full Scale Manufacturing.

Glide Pharma

Glide Pharma, formerly Caretek Medical, is a specialty pharmaceutical company developing products for easy, safe and convenient delivery of pharmaceuticals and vaccines using its Glide SDI - the Solid Dose Injector. By being much less invasive than traditional injection methods, Glide improves the treatment experience of both patients and carers and, by allowing the injection of solid formulations, opens up a wide range of therapeutic options for new and existing treatments.

MedManage Systems

MedManage Systems, Inc. aims to provide drug sampling solutions. The company's OmniSampleSM Solution aims to allow pharmaceutical companies to intensify physician use of trial medications, thereby increasing product revenues.

Azaya Therapeutics

Azaya is a nanotherapy company utilizing a patented drug delivery technology platform. The tumor-targeted technology aims to allow the company to reformulate marketed chemotherapy drugs to increase their safety and effectiveness.

Next Breath

Next Breath, LLC is a contract pharmaceutical research and development organization dedicated to pre-clinical identification and evaluation of commercially viable respiratory and nasal drug delivery platforms. NB's business will discover and exploit optimal drug and delivery device combinations that will increase the company's partners' probability of success when their products advance into human clinical trials and the marketplace. Next Breath seeks to meet the pharmaceutical industry's outsourcing needs and to provide intellectual expertise to biotechnology companies that are developing inhalation products.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.